These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Development of a model for the delta-opioid receptor pharmacophore: 3. Comparison of the cyclic tetrapeptide, Tyr-c[D-Cys-Phe-D-Pen]OH with other conformationally constrained delta-receptor selective ligands. Lomize AL, Pogozheva ID, Mosberg HI. Biopolymers; 1996 Feb; 38(2):221-34. PubMed ID: 8589255 [Abstract] [Full Text] [Related]
4. Development of a model for the delta-opioid receptor pharmacophore. 4. Residue 3 dehydrophenylalanine analogues of Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13) confirm required gauche orientation of aromatic side chain. Mosberg HI, Dua RK, Pogozheva ID, Lomize AL. Biopolymers; 1996 Sep; 39(3):287-96. PubMed ID: 8756510 [Abstract] [Full Text] [Related]
8. Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists. Schiller PW, Nguyen TM, Weltrowska G, Wilkes BC, Marsden BJ, Lemieux C, Chung NN. Proc Natl Acad Sci U S A; 1992 Dec 15; 89(24):11871-5. PubMed ID: 1334552 [Abstract] [Full Text] [Related]
11. Synthesis and biological activities of cyclic lanthionine enkephalin analogues: delta-opioid receptor selective ligands. Rew Y, Malkmus S, Svensson C, Yaksh TL, Chung NN, Schiller PW, Cassel JA, DeHaven RN, Taulane JP, Goodman M. J Med Chem; 2002 Aug 15; 45(17):3746-54. PubMed ID: 12166947 [Abstract] [Full Text] [Related]
12. Pseudoproline-containing analogues of morphiceptin and endomorphin-2: evidence for a cis Tyr-Pro amide bond in the bioactive conformation. Keller M, Boissard C, Patiny L, Chung NN, Lemieux C, Mutter M, Schiller PW. J Med Chem; 2001 Nov 08; 44(23):3896-903. PubMed ID: 11689075 [Abstract] [Full Text] [Related]
15. Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile. Tourwé D, Mannekens E, Diem TN, Verheyden P, Jaspers H, Tóth G, Péter A, Kertész I, Török G, Chung NN, Schiller PW. J Med Chem; 1998 Dec 17; 41(26):5167-76. PubMed ID: 9857087 [Abstract] [Full Text] [Related]
16. Substitution of aromatic and nonaromatic amino acids for the Phe3 residue in the delta-selective opioid peptide deltorphin I: effects on binding affinity and selectivity. Heyl DL, Schmitter SJ, Bouzit H, Johnson TW, Hepp AM, Kurtz KR, Mousigian C. Int J Pept Protein Res; 1994 Nov 17; 44(5):420-6. PubMed ID: 7896499 [Abstract] [Full Text] [Related]
18. Phe3-substituted analogues of deltorphin C. Spatial conformation and topography of the aromatic ring in peptide recognition by delta opioid receptors. Salvadori S, Bryant SD, Bianchi C, Balboni G, Scaranari V, Attila M, Lazarus LH. J Med Chem; 1993 Nov 26; 36(24):3748-56. PubMed ID: 8254604 [Abstract] [Full Text] [Related]
19. Opiate aromatic pharmacophore structure-activity relationships in CTAP analogues determined by topographical bias, two-dimensional NMR, and biological activity assays. Bonner GG, Davis P, Stropova D, Edsall S, Yamamura HI, Porreca F, Hruby VJ. J Med Chem; 2000 Feb 24; 43(4):569-80. PubMed ID: 10691683 [Abstract] [Full Text] [Related]